Skip to Content
Merck
CN

F1179

FPL-55712

≥97% (HPLC), solid

Synonym(s):

7-[3-(4-Acetyl-3-hydroxy-2-propylphenoxy)-2-hydroxypropoxy]- 4-oxo-8-propyl-4H-1-benzopyran-2-carboxylic acid sodium salt

Sign In to View Organizational & Contract Pricing.

Select a Size

About This Item

Empirical Formula (Hill Notation):
C27H29O9Na
CAS Number:
40786-08-1
Molecular Weight:
520.50
NACRES:
NA.77
PubChem Substance ID:
329799675
UNSPSC Code:
12352202
MDL number:
MFCD00068619
Assay:
≥97% (HPLC)
Form:
solid

Key Documents

View All Documentation
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist

InChI

1S/C27H30O9.Na/c1-4-6-19-22(10-8-17(15(3)28)25(19)31)34-13-16(29)14-35-23-11-9-18-21(30)12-24(27(32)33)36-26(18)20(23)7-5-2;/h8-12,16,29,31H,4-7,13-14H2,1-3H3,(H,32,33);/q;+1/p-1

SMILES string

[Na+].CCCc1c(O)c(ccc1OCC(O)COc2ccc3C(=O)C=C(Oc3c2CCC)C([O-])=O)C(C)=O

InChI key

ZDEVPOBNLIVGFA-UHFFFAOYSA-M

assay

≥97% (HPLC)

form

solid

color

off-white

mp

150-160 °C

solubility

H2O: ≥15 mg/mL, clear, yellow

storage temp.

−20°C

Biochem/physiol Actions

CysLT1 leukotriene receptor antagonist.

Storage Class

11 - Combustible Solids

wgk

WGK 3

flash_point_f

Not applicable

flash_point_c

Not applicable

ppe

Eyeshields, Gloves, type N95 (US)

Regulatory Information

新产品
This item has

Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number
064K4605

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Search for a COA

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Leukotriene cysLT1 (LTD4) receptor antagonism of H1-antihistamines: an in vitro study.
M Q Zhang et al.
Inflammation research : official journal of the European Histamine Research Society ... [et al.], 46 Suppl 1, S93-S94 (1997-03-01)
T Obata et al.
Life sciences, 52(12), PL97-P102 (1993-01-01)
The effect of a peptide leukotriene receptor antagonist ONO-1078 on the production of thromboxane (Tx) B2 induced by leukotriene (LT) D4 and antigen challenge was examined in guinea pig lungs. LTD4 (1-1,000 nM) induced a concentration-dependent production of TxB2 in
A Shekher et al.
Methods and findings in experimental and clinical pharmacology, 19(4), 223-229 (1997-05-01)
The effects of FPL-55712 (leukotriene receptor antagonist) and OKY-046 (thromboxane synthase inhibitor) were studied on ischemic and reperfused myocardium using in vivo and in vitro rat heart paradigms. The in vivo studies included production of regional ischemia by coronary artery
C M Rodríguez-Ortigosa et al.
Gastroenterology, 108(6), 1793-1801 (1995-06-01)
Cysteinyl-containing leukotrienes seem to exert a cholestatic effect. However, leukotriene inhibitors were found to reduce bile salt efflux in isolated rat hepatocytes, suggesting a role for leukotrienes in bile flow formation. In the isolated rat liver, the effects of two
B J Hopkins et al.
Toxicon : official journal of the International Society on Toxinology, 32(10), 1197-1210 (1994-10-01)
The present study was designed to examine some of the pharmacological properties of venom from the stonefish (Synanceja trachynis), with particular reference to the presence in the venom of pain-producing/enhancing substances. Stonefish venom (1-6 micrograms/ml) produced concentration-dependent contractile responses in
View All Related Papers

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service